Literature DB >> 33433576

Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses in the US, 2010-2017.

Ashley H Hirai1, Jean Y Ko2,3, Pamela L Owens4, Carol Stocks5,6, Stephen W Patrick2,7,8,9.   

Abstract

Importance: Substantial increases in both neonatal abstinence syndrome (NAS) and maternal opioid use disorder have been observed through 2014. Objective: To examine national and state variation in NAS and maternal opioid-related diagnoses (MOD) rates in 2017 and to describe national and state changes since 2010 in the US, which included expanded MOD codes (opioid use disorder plus long-term and unspecified use) implemented in International Classification of Disease, 10th Revision, Clinical Modification. Design, Setting, and Participants: Repeated cross-sectional analysis of the 2010 to 2017 Healthcare Cost and Utilization Project's National Inpatient Sample and State Inpatient Databases, an all-payer compendium of hospital discharge records from community nonrehabilitation hospitals in 47 states and the District of Columbia. Exposures: State and year. Main Outcomes and Measures: NAS rate per 1000 birth hospitalizations and MOD rate per 1000 delivery hospitalizations.
Results: In 2017, there were 751 037 birth hospitalizations and 748 239 delivery hospitalizations in the national sample; 5375 newborns had NAS and 6065 women had MOD documented in the discharge record. Mean gestational age was 38.4 weeks and mean maternal age was 28.8 years. From 2010 to 2017, the estimated NAS rate significantly increased by 3.3 per 1000 birth hospitalizations (95% CI, 2.5-4.1), from 4.0 (95% CI, 3.3-4.7) to 7.3 (95% CI, 6.8-7.7). The estimated MOD rate significantly increased by 4.6 per 1000 delivery hospitalizations (95% CI, 3.9-5.4), from 3.5 (95% CI, 3.0-4.1) to 8.2 (95% CI, 7.7-8.7). Larger increases for MOD vs NAS rates occurred with new International Classification of Disease, 10th Revision, Clinical Modification codes in 2016. From a census of 47 state databases in 2017, NAS rates ranged from 1.3 per 1000 birth hospitalizations in Nebraska to 53.5 per 1000 birth hospitalizations in West Virginia, with Maine (31.4), Vermont (29.4), Delaware (24.2), and Kentucky (23.9) also exceeding 20 per 1000 birth hospitalizations, while MOD rates ranged from 1.7 per 1000 delivery hospitalizations in Nebraska to 47.3 per 1000 delivery hospitalizations in Vermont, with West Virginia (40.1), Maine (37.8), Delaware (24.3), and Kentucky (23.4) also exceeding 20 per 1000 delivery hospitalizations. From 2010 to 2017, NAS and MOD rates increased significantly for all states except Nebraska and Vermont, which only had MOD increases. Conclusions and Relevance: In the US from 2010 to 2017, estimated rates of NAS and MOD significantly increased nationally and for the majority of states, with notable state-level variation.

Entities:  

Mesh:

Year:  2021        PMID: 33433576      PMCID: PMC7804920          DOI: 10.1001/jama.2020.24991

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  19 in total

Review 1.  Adjusting Health Expenditures for Inflation: A Review of Measures for Health Services Research in the United States.

Authors:  Abe Dunn; Scott D Grosse; Samuel H Zuvekas
Journal:  Health Serv Res       Date:  2016-11-21       Impact factor: 3.402

2.  Rural and Urban Differences in Neonatal Abstinence Syndrome and Maternal Opioid Use, 2004 to 2013.

Authors:  Nicole L G Villapiano; Tyler N A Winkelman; Katy B Kozhimannil; Matthew M Davis; Stephen W Patrick
Journal:  JAMA Pediatr       Date:  2017-02-01       Impact factor: 16.193

3.  Amphetamine- and Opioid-Affected Births: Incidence, Outcomes, and Costs, United States, 2004-2015.

Authors:  Lindsay K Admon; Gavin Bart; Katy B Kozhimannil; Caroline R Richardson; Vanessa K Dalton; Tyler N A Winkelman
Journal:  Am J Public Health       Date:  2018-11-29       Impact factor: 9.308

4.  Association Among County-Level Economic Factors, Clinician Supply, Metropolitan or Rural Location, and Neonatal Abstinence Syndrome.

Authors:  Stephen W Patrick; Laura J Faherty; Andrew W Dick; Theresa A Scott; Judith Dudley; Bradley D Stein
Journal:  JAMA       Date:  2019-01-29       Impact factor: 56.272

5.  Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009.

Authors:  Stephen W Patrick; Robert E Schumacher; Brian D Benneyworth; Elizabeth E Krans; Jennifer M McAllister; Matthew M Davis
Journal:  JAMA       Date:  2012-04-30       Impact factor: 56.272

Review 6.  Standardization of State Definitions for Neonatal Abstinence Syndrome Surveillance and the Opioid Crisis.

Authors:  Katelyn V Chiang; Ekwutosi M Okoroh; Laurin J Kasehagen; Luigi F Garcia-Saavedra; Jean Y Ko
Journal:  Am J Public Health       Date:  2019-07-18       Impact factor: 9.308

Review 7.  Neonatal abstinence syndrome.

Authors:  Prabhakar Kocherlakota
Journal:  Pediatrics       Date:  2014-08       Impact factor: 7.124

8.  Opioid Use Disorder Documented at Delivery Hospitalization - United States, 1999-2014.

Authors:  Sarah C Haight; Jean Y Ko; Van T Tong; Michele K Bohm; William M Callaghan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-08-10       Impact factor: 17.586

9.  State Strategies to Address Opioid Use Disorder Among Pregnant and Postpartum Women and Infants Prenatally Exposed to Substances, Including Infants with Neonatal Abstinence Syndrome.

Authors:  Charlan D Kroelinger; Marion E Rice; Shanna Cox; Hadley R Hickner; Mary Kate Weber; Lisa Romero; Jean Y Ko; Donna Addison; Trish Mueller; Carrie Shapiro-Mendoza; S Nicole Fehrenbach; Margaret A Honein; Wanda D Barfield
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-09-13       Impact factor: 17.586

View more
  29 in total

1.  Prenatal opioid exposure reprograms the behavioural response to future alcohol reward.

Authors:  Gregory G Grecco; David L Haggerty; Kaitlin C Reeves; Yong Gao; Danielle Maulucci; Brady K Atwood
Journal:  Addict Biol       Date:  2022-03       Impact factor: 4.280

2.  Prescription opioid use among women of reproductive age in the United States: NHANES, 2003-2018.

Authors:  Amanda L Elmore; Omonefe O Omofuma; Maria Sevoyan; Chelsea Richard; Jihong Liu
Journal:  Prev Med       Date:  2021-10-13       Impact factor: 4.018

3.  Breastfeeding Experiences in Women from Ten States Reporting Opioid Use Before or During Pregnancy: PRAMS, Phase 8.

Authors:  Madeleine Jade Bremer; Kerri Lynn Knippen
Journal:  Matern Child Health J       Date:  2022-08-10

4.  Stressful life events and prescription opioid use during pregnancy: findings from the 2019 pregnancy risk assessment monitoring system.

Authors:  Alexander Testa; Allison D Crawford; Dylan B Jackson; Alison Gemmill
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-08-10       Impact factor: 4.519

5.  A retrospective, observational study on medication for opioid use disorder during pregnancy and risk for neonatal abstinence syndrome.

Authors:  Ayesha Sujan; Emma Cleary; Edie Douglas; Rubin Aujla; Lisa Boyars; Claire Smith; Constance Guille
Journal:  Fam Pract       Date:  2022-03-24       Impact factor: 2.290

6.  Perinatal Morphine Exposure Leads to Sex-Dependent Executive Function Deficits and Microglial Changes in Mice.

Authors:  Brittany L Smith; Tess A Guzman; Alexander H Brendle; Collin J Laaker; Alexis Ford; Adam R Hiltz; Junfang Zhao; Kenneth D R Setchell; Teresa M Reyes
Journal:  eNeuro       Date:  2022-10-17

7.  Association of State Child Abuse Policies and Mandated Reporting Policies With Prenatal and Postpartum Care Among Women Who Engaged in Substance Use During Pregnancy.

Authors:  Anna E Austin; Rebecca B Naumann; Elizabeth Simmons
Journal:  JAMA Pediatr       Date:  2022-09-19       Impact factor: 26.796

8.  Laws Forbidding Pregnancy Discrimination in Substance Use Disorder Treatment Are Not Associated With Treatment Access.

Authors:  Corey S Davis; Elizabeth McNeer; Stephen W Patrick
Journal:  J Addict Med       Date:  2022 May-Jun 01       Impact factor: 4.647

Review 9.  Perinatal insurance coverage and behavioural health-related maternal mortality.

Authors:  Lindsay K Admon; Kara Zivin; Katy B Kozhimannil
Journal:  Int Rev Psychiatry       Date:  2021-06-07

10.  Prenatal opioid administration induces shared alterations to the maternal and offspring gut microbiome: A preliminary analysis.

Authors:  Gregory G Grecco; Yong Gao; Hongyu Gao; Yunlong Liu; Brady K Atwood
Journal:  Drug Alcohol Depend       Date:  2021-07-28       Impact factor: 4.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.